JP2009535385A5 - - Google Patents

Download PDF

Info

Publication number
JP2009535385A5
JP2009535385A5 JP2009508455A JP2009508455A JP2009535385A5 JP 2009535385 A5 JP2009535385 A5 JP 2009535385A5 JP 2009508455 A JP2009508455 A JP 2009508455A JP 2009508455 A JP2009508455 A JP 2009508455A JP 2009535385 A5 JP2009535385 A5 JP 2009535385A5
Authority
JP
Japan
Prior art keywords
amino
hydrogen
optionally substituted
alkyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009508455A
Other languages
English (en)
Japanese (ja)
Other versions
JP5340918B2 (ja
JP2009535385A (ja
Filing date
Publication date
Priority claimed from GB0608855A external-priority patent/GB0608855D0/en
Priority claimed from GB0613914A external-priority patent/GB0613914D0/en
Application filed filed Critical
Priority claimed from PCT/GB2007/001596 external-priority patent/WO2007129040A1/en
Publication of JP2009535385A publication Critical patent/JP2009535385A/ja
Publication of JP2009535385A5 publication Critical patent/JP2009535385A5/ja
Application granted granted Critical
Publication of JP5340918B2 publication Critical patent/JP5340918B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009508455A 2006-05-04 2007-05-01 p38MAPキナーゼ阻害剤 Expired - Fee Related JP5340918B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0608855.3 2006-05-04
GB0608855A GB0608855D0 (en) 2006-05-04 2006-05-04 Inhibitors of MAP kinase enzymes
GB0613914.1 2006-07-13
GB0613914A GB0613914D0 (en) 2006-07-13 2006-07-13 Inhibitors of p38 map kinase
PCT/GB2007/001596 WO2007129040A1 (en) 2006-05-04 2007-05-01 p38 MAP KINASE INHIBITORS

Publications (3)

Publication Number Publication Date
JP2009535385A JP2009535385A (ja) 2009-10-01
JP2009535385A5 true JP2009535385A5 (https=) 2010-06-17
JP5340918B2 JP5340918B2 (ja) 2013-11-13

Family

ID=38268953

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009508455A Expired - Fee Related JP5340918B2 (ja) 2006-05-04 2007-05-01 p38MAPキナーゼ阻害剤

Country Status (15)

Country Link
US (1) US8044211B2 (https=)
EP (1) EP2013175B9 (https=)
JP (1) JP5340918B2 (https=)
KR (1) KR101429780B1 (https=)
CN (1) CN102942520B (https=)
AU (1) AU2007246869B2 (https=)
BR (1) BRPI0711310B8 (https=)
CA (1) CA2650970C (https=)
CY (1) CY1118518T1 (https=)
DK (1) DK2013175T5 (https=)
ES (1) ES2605727T3 (https=)
HU (1) HUE033281T2 (https=)
NZ (1) NZ573348A (https=)
PT (1) PT2013175T (https=)
WO (1) WO2007129040A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0619753D0 (en) 2006-10-06 2006-11-15 Chroma Therapeutics Ltd Enzyme inhibitors
US8962825B2 (en) * 2006-10-30 2015-02-24 Glaxosmithkline Intellectual Property Development Limited Hydroxamates as inhibitors of histone deacetylase
EP2170848B1 (en) 2007-06-27 2014-10-22 AstraZeneca AB Pyrazinone derivatives and their use in the treatment of lung diseases
EP2220044A1 (en) * 2007-11-07 2010-08-25 Chroma Therapeutics Limited P38 map kinase inhibitors
US8778953B2 (en) 2008-02-29 2014-07-15 Chroma Therapeutics Ltd. Inhibitors of P38 map kinase
GB0803747D0 (en) 2008-02-29 2008-04-09 Martin Enzyme and receptor modulation
CA2726588C (en) 2008-06-03 2019-04-16 Karl Kossen Compounds and methods for treating inflammatory and fibrotic disorders
AR073711A1 (es) 2008-10-01 2010-11-24 Astrazeneca Ab Derivados de isoquinolina
GB0903480D0 (en) 2009-02-27 2009-04-08 Chroma Therapeutics Ltd Enzyme Inhibitors
GB201211310D0 (en) 2012-06-26 2012-08-08 Chroma Therapeutics Ltd CSF-1R kinase inhibitors
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
HUE046132T2 (hu) 2012-10-17 2020-02-28 Macrophage Pharma Ltd N-[2-{4-[6-amino-5-(2,4-difluor-benzoil)-2-oxopiridin-1(2H)-il]-3,5-difluor-fenil}etil]-l-alanin és annak tercbutil-észtere
GB201306901D0 (en) * 2013-04-16 2013-05-29 Chroma Therapeutics Ltd Combination
MX382781B (es) 2014-04-02 2025-03-13 Intermune Inc Piridinonas anti-fibroticas.
GB201713975D0 (en) 2017-08-31 2017-10-18 Macrophage Pharma Ltd Medical use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04008822A (es) 2002-03-14 2004-11-26 Bayer Healthcare Ag Aroilpiridinonas monociclicas.
BRPI0610368A8 (pt) * 2005-05-05 2015-09-08 Glaxosmithkline Ip Dev Ltd Modulação de enzima e de receptor
US8778953B2 (en) * 2008-02-29 2014-07-15 Chroma Therapeutics Ltd. Inhibitors of P38 map kinase

Similar Documents

Publication Publication Date Title
JP2009535385A5 (https=)
JP2009535387A5 (https=)
JP2010505802A5 (https=)
JP2011513288A5 (https=)
JP2010508336A5 (https=)
CY1107238T1 (el) Παρασκευη μιας πολυμορφικης μορφης ενος παραγωγου θειαζολιδινοδιονης
IL182647A0 (en) An oral preparation having improved bioavailability
JP2011527334A5 (https=)
TR200103851T2 (tr) Bir antidiyabetik maddenin yeni polimorfik formları, bunların hazırlanması için işlem ve bunları farmasötik bileşimler
JP2010508362A5 (https=)
RU2007138584A (ru) Соединения, обладающие активностью для коррекции процессинга мутантного cftr, и их применение
JP2004516314A5 (https=)
JP2007534702A5 (https=)
RU99105567A (ru) Производные пропионовой кислоты и их использование
JPH10279578A5 (https=)
JP2007510662A5 (https=)
JP2013542980A5 (https=)
SI20876B (sl) Derivati propanojske kisline, ki inhibirajo vezavo integrinov na njihove receptorje
RU2004135542A (ru) Производные бензойной кислоты как модуляторы ppara и ppary
JP2007500222A5 (https=)
JP2017518363A5 (https=)
JP2005514452A5 (https=)
RU2401267C2 (ru) Замещенные производные бензохинолизина
JP2005511594A5 (https=)
JP2011510072A5 (https=)